Heterologous production of natural products in non-native bacteria can be used to increase yields of certain bioactive compounds; however, producing small molecules inside bacteria has numerous limitations. Two reports of the in vitro reconstruction of entire biosynthetic pathways highlight the advantages and challenges of this approach for pathway engineering.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fischbach, M.A. & Walsh, C.T. Chem. Rev. 106, 3468–3496 (2006).
Cheng, Q., Xiang, L., Izumikawa, M., Meluzzi, D. & Moore, B.S. Nat. Chem. Biol. 3, 557–558 (2007).
Balibar, C.J., Howard-Jones, A.R. & Walsh, C.T. Nat. Chem. Biol. 3, 584–592 (2007).
Galm, U. & Shen, B. Expert Opin. Drug Discov. 1, 409–437 (2006).
Baran, P.S., Maimone, T.J. & Richter, J.M. Nature 446, 404–408 (2007).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Fecik, R. Natural product biosynthesis moves in vitro. Nat Chem Biol 3, 531–532 (2007). https://doi.org/10.1038/nchembio0907-531
Issue Date:
DOI: https://doi.org/10.1038/nchembio0907-531
This article is cited by
-
In vitro reconstruction of tetronate RK-682 biosynthesis
Nature Chemical Biology (2010)